安旭生物: 安旭生物2025年第一次临时股东大会决议公告

Core Points - The company held a shareholders' meeting on August 22, 2025, in Hangzhou, Zhejiang Province, with a total of 46 ordinary shareholders present, representing 81,577,525 voting rights, which accounts for 64.1924% of the company's total voting rights [1][2][3] - The meeting adopted a combination of on-site and online voting methods, and all voting procedures complied with the Company Law and the company's articles of association [1][2] - All non-cumulative voting proposals were approved, with the majority of votes in favor, including the election of non-independent directors and independent directors [2][3] Voting Results - The proposal to elect Ling Shisheng as a non-independent director received 81,524,714 votes in favor, accounting for 99.9352% of the votes [1][2] - The proposal to elect Jiang Xueying as a non-independent director received 81,526,924 votes in favor, accounting for 99.9379% of the votes [1][2] - The independent director election proposals also received high approval rates, with all candidates receiving over 99.6500% of the votes in favor [2][3] Legal Compliance - The meeting and voting procedures were confirmed to be in accordance with the relevant laws and regulations, ensuring the legality and validity of the resolutions passed [3]